*Some Market data delayed by 15 mins.

Werewolf Therapeutics, Inc. Common Stock

Symbol: HOWL (NASDAQ)
2.69 ▼ (-1.82%) -0.050

Company Description:
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Key Stats
  • Today's Open: $2.76
  • Today's High: $2.985
  • Today's Low: $2.62
  • Today's Volume: 479.85K
  • Yesterday Close: $2.74
  • Yesterday High: $2.77
  • Yesterday Low: $2.24
  • Yesterday Volume: 574.95K
  • Last Min Volume: 20
  • Last Min High: $2.69
  • Last Min Low: $2.69
  • Last Min VWAP: $2.69
Company Profile
  • Name: Werewolf Therapeutics, Inc. Common Stock
  • Website: https://www.werewolftx.com
  • Listed Date: 2021-04-30
  • Location: WATERTOWN, MA
  • Market Status: Active
  • CIK Number: 0001785530
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $116.89M
  • Round Lot: 100
  • Outstanding Shares: 43.46M
  • Asset Type: CS
RECENT FILINGS FOR HOWL
Filing DateFiling TypeFormat
2024-06-258-KView
2024-06-038-KView
2024-05-288-KView
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-244View
2024-05-07SC 13D/AView
2024-05-0310-QView
2024-05-038-KView
2024-04-12ARSView
2024-04-12DEFA14AView
2024-04-12DEF 14AView
2024-03-07S-8View
2024-03-0710-KView
2024-03-078-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.